Literature DB >> 28185483

Genital nerve stimulation is tolerable and effective for bladder inhibition in sensate individuals with incomplete SCI.

Steven W Brose1,2,3,4, Dennis J Bourbeau1,4, Kenneth J Gustafson1,4,5.   

Abstract

BACKGROUND: Neurogenic detrusor overactivity after spinal cord injury (SCI) causes urinary incontinence and reduces bladder capacity. Surface electrical genital nerve stimulation (GNS) acutely inhibits reflex bladder contractions. The stimulation amplitude selected for GNS is typically twice the amplitude that is required to evoke the pudendal-anal reflex. There is concern about the ability of persons with sensation to comfortably tolerate effective levels of GNS. The objective of this work is to determine if persons with incomplete SCI are able to tolerate acute GNS for bladder inhibition.
METHODS: Twenty-four subjects with neurogenic detrusor overactivity, SCI, and pelvic sensation were enrolled in this case series. The setting was the Spinal Cord Injury Service of a Veterans Affairs Medical Center. Primary outcome measures were sensation threshold and tolerable stimulation amplitude; secondary outcome measures were bladder capacity and bladder contraction inhibition.
RESULTS: GNS was tolerable up to 30±16 mA (range 8 mA to ≥60 mA) at amplitudes greater than twice the pudendal-anal (PA) reflex threshold, which was 8±5 mA (range 4 mA to 20 mA). Twelve subjects tolerated GNS at greater than twice the PA, six tolerated 1-1.5 times the PA, and five had no identifiable PA. GNS at tolerable amplitudes inhibited reflexive bladder contractions or increased bladder capacity 135±109 mL (n=23). GNS did not cause autonomic dysreflexia or intolerable spasticity.
CONCLUSIONS: GNS is tolerable at amplitudes that effectively inhibit neurogenic detrusor overactivity in individuals with pelvic sensation. GNS therefore is a tool with potential clinical applications for persons with preserved sensation.

Entities:  

Keywords:  Electrical stimulation; Genital nerve stimulation; Neurogenic bladder; Spinal cord injury

Mesh:

Year:  2017        PMID: 28185483      PMCID: PMC5901453          DOI: 10.1080/10790268.2017.1279817

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  20 in total

1.  A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence.

Authors:  W F Bower; K H Moore; R D Adams
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

2.  The acute effects of continuous and conditional neuromodulation on the bladder in spinal cord injury.

Authors:  A P Kirkham; N C Shah; S L Knight; P J Shah; M D Craggs
Journal:  Spinal Cord       Date:  2001-08       Impact factor: 2.772

3.  Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms.

Authors:  Howard B Goldman; Cindy L Amundsen; Jeffrey Mangel; Julie Grill; Maria Bennett; Kenneth J Gustafson; Warren M Grill
Journal:  Neurourol Urodyn       Date:  2008       Impact factor: 2.696

4.  Subject-controlled stimulation of dorsal genital nerve to treat neurogenic detrusor overactivity at home.

Authors:  Eloy Opisso; Albert Borau; Nico J M Rijkhoff
Journal:  Neurourol Urodyn       Date:  2012-12-31       Impact factor: 2.696

5.  Detrusor and blood pressure responses to dorsal penile nerve stimulation during hyperreflexic contraction of the bladder in patients with cervical cord injury.

Authors:  Young-Hee Lee; Graham H Creasey; Hyunkyo Lim; Jaemann Song; Kihak Song; Jinweon Kim
Journal:  Arch Phys Med Rehabil       Date:  2003-01       Impact factor: 3.966

6.  Targeting recovery: priorities of the spinal cord-injured population.

Authors:  Kim D Anderson
Journal:  J Neurotrauma       Date:  2004-10       Impact factor: 5.269

7.  Treatment of neurogenic detrusor overactivity in spinal cord injured patients by conditional electrical stimulation.

Authors:  J Hansen; S Media; M Nøhr; F Biering-Sørensen; T Sinkjaer; N J M Rijkhoff
Journal:  J Urol       Date:  2005-06       Impact factor: 7.450

8.  Conditional stimulation of the dorsal penile/clitoral nerve may increase cystometric capacity in patients with spinal cord injury.

Authors:  A L Dalmose; N J M Rijkhoff; H J Kirkeby; M Nohr; T Sinkjaer; J C Djurhuus
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

9.  Patient controlled versus automatic stimulation of pudendal nerve afferents to treat neurogenic detrusor overactivity.

Authors:  E Opisso; A Borau; A Rodríguez; J Hansen; N J M Rijkhoff
Journal:  J Urol       Date:  2008-08-16       Impact factor: 7.450

10.  Management of incontinent SCI patients with penile stimulation: preliminary results.

Authors:  J S Wheeler; J S Walter; P Sibley
Journal:  J Am Paraplegia Soc       Date:  1994-04
View more
  4 in total

1.  Targeting bladder function with network-specific epidural stimulation after chronic spinal cord injury.

Authors:  April N Herrity; Sevda C Aslan; Samineh Mesbah; Ricardo Siu; Karthik Kalvakuri; Beatrice Ugiliweneza; Ahmad Mohamed; Charles H Hubscher; Susan J Harkema
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

2.  At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: A pilot feasibility study.

Authors:  Dennis J Bourbeau; Kenneth J Gustafson; Steven W Brose
Journal:  J Spinal Cord Med       Date:  2018-01-15       Impact factor: 1.985

3.  Effects of Genital Nerve Stimulation Amplitude on Bladder Capacity in Spinal Cord Injured Subjects.

Authors:  Shauh-Der Yeh; Bor-Shing Lin; Shih-Ching Chen; Chih-Hwa Chen; Kenneth J Gustafson; Dennis J Bourbeau; Chellappan Praveen Rajneesh; Chih-Wei Peng
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-24       Impact factor: 2.629

4.  A Urodynamic Comparison of Neural Targets for Transcutaneous Electrical Stimulation to Acutely Suppress Detrusor Contractions Following Spinal Cord Injury.

Authors:  Sean Doherty; Anne Vanhoestenberghe; Lynsey Duffell; Rizwan Hamid; Sarah Knight
Journal:  Front Neurosci       Date:  2019-12-17       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.